The Use And Sequencing Of Tyrosine Kinase Inhibitors (TKI’s) In Hepatocellular Carcinoma (HCC) - 101341

Spotlight
Video

The Use And Sequencing Of Tyrosine Kinase Inhibitors (TKI’s) In Hepatocellular Carcinoma (HCC)

obr has 439 videos Subscribe Here

Loading........
Description: Only one TKI is approved in a first line setting. Joining us from the 2018 Gastrointestinal Cancers Symposium is Dr. Richard Kim, MD, Gastrointestinal Oncology Department, Moffitt Cancer Center, Assistant Professor of Oncology, University of South Florida College of Medicine, describes the different TKI's and their uses and also the status of sequencing them.
Shared By : obr
Posted on : 01/30/18
Added : 8 months ago